Cargando…
In Response to: ‘Impact of Glycosylation on Effector Functions of Therapeutic IgG’ (Pharmaceuticals 2010, 3, 146–157)
To complete the review article by Abes and colleagues (Pharmaceuticals 2010, 3, 146–157) which provides a good overview on recently developed approaches for generation of glyco-modified antibodies and the impact of glyco-modification of antibodies on their effector functions, important information s...
Autores principales: | Nechansky, Andreas, Koller, Iris, Kircheis, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033957/ https://www.ncbi.nlm.nih.gov/pubmed/27713333 http://dx.doi.org/10.3390/ph3061887 |
Ejemplares similares
-
Impact of Glycosylation on Effector Functions of Therapeutic IgG †
por: Abès, Riad, et al.
Publicado: (2010) -
The antiinflammatory activity of IgG: the intravenous IgG paradox
por: Nimmerjahn, Falk, et al.
Publicado: (2007) -
The Ligands for Human IgG and Their Effector Functions
por: de Taeye, Steven W., et al.
Publicado: (2019) -
IgE, IgG1, and IgG4 Reactivity to Dermatophagoides pteronyssinus Glycosylated Extract in Allergic Patients
por: Resende, Rafael de Oliveira, et al.
Publicado: (2019) -
Glycosylation of plasma IgG in colorectal cancer prognosis
por: Theodoratou, Evropi, et al.
Publicado: (2016)